Guidelines for stereotactic body radiation therapy treatment of lung cancer highlight important research questions: what is the next step?
- PMID: 29708155
- PMCID: PMC5906265
- DOI: 10.21037/jtd.2018.03.36
Guidelines for stereotactic body radiation therapy treatment of lung cancer highlight important research questions: what is the next step?
Conflict of interest statement
Conflicts of Interest: Dr. Cornwell receives research funding from the Department of Veteran Affairs Cooperative Studies Program at the Michael E. DeBakey VA Medical Center in support of the VALOR trial. The other authors have no conflicts of interest to declare.
Comment on
-
Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.J Clin Oncol. 2018 Mar 1;36(7):710-719. doi: 10.1200/JCO.2017.74.9671. Epub 2017 Nov 6. J Clin Oncol. 2018. PMID: 29106810
References
-
- Schneider BJ, Daly ME, Kennedy EB, et al. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. J Clin Oncol 2018;36:710-9. 10.1200/JCO.2017.74.9671 - DOI - PubMed
-
- Haque W, Szeja S, Tann A, et al. Changes in Treatment Patterns and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in the United States After the Incorporation of Stereotactic Ablative Radiation Therapy: A Population-based Analysis. Am J Clin Oncol 2018;41:259-66. - PubMed
-
- Timmerman RD, Hu C, Michalski J, et al. Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer. International Journal of Radiation Oncology 2014;90:S30 10.1016/j.ijrobp.2014.05.135 - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources